The miR-7-5p inhibitor blocked LPS-induced LX-2 cell proliferation and activation. LX-2 cells were treated with the NC or miR-7-5p inhibitor with or without 100 ng/ml LPS. (a) miR-7-5p levels in LX-2 cells measured by qRT-PCR. (b) OD 450 was measured for 0, 12, 24, and 48 hours later with CCK-8 reagents. (c) The levels of hydroxyproline content in LX-2 cells measured with a hydroxyproline assay kit. (d) mRNA levels of FGFR4, TGF-β1, α-SMA, and COL1A1. (e) Protein levels of FGFR4, TGF-β1, α-SMA, and COL1A1 measured by western blot. LPS: lipopolysaccharides; NC: scramble-miR control. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 versus control; #P < 0.05, ##P < 0.01, and ###P < 0.001 versus NC+LPS.